IHE was created on 2006-05-01 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 1547.92m in AUM and 55 holdings. IHE tracks a broad-based, cap-weighted index of US pharmaceutical companies.
What is the current price of iShares U.S. Pharmaceuticals ETF (IHE)?
The current price of iShares U.S. Pharmaceuticals ETF (IHE) is 106.60. Market data may be delayed; please refer to the timestamp displayed on the page.
What is the 52-week high of iShares U.S. Pharmaceuticals ETF?
The 52-week high of iShares U.S. Pharmaceuticals ETF is 110.44. Please refer to the page timestamp for the latest data.
What is the 52-week low of iShares U.S. Pharmaceuticals ETF?
The 52-week low of iShares U.S. Pharmaceuticals ETF is 74.89. Please refer to the page timestamp for the latest data.
What is the NAV of iShares U.S. Pharmaceuticals ETF?
The NAV of iShares U.S. Pharmaceuticals ETF is 102.48 today. NAV represents the fund’s total assets minus its liabilities and helps indicate its underlying per-share value.
How is iShares U.S. Pharmaceuticals ETF (IHE) performing?
The trading turnover of iShares U.S. Pharmaceuticals ETF (IHE) is 1.15M. Its price changed by 6.40% over the past month, while its one-year return is 39.87%. View the iShares U.S. Pharmaceuticals ETF price chart for more details.
Is iShares U.S. Pharmaceuticals ETF (IHE) a safe investment?
No investment is completely risk-free. The risk level of iShares U.S. Pharmaceuticals ETF (IHE) depends on its underlying assets, strategy, liquidity, fees, and market conditions. Diversification may reduce potential losses but cannot eliminate them, and past performance does not guarantee future results. Before investing, consider whether the fund aligns with your goals and risk tolerance. This is not investment advice.